Table 2.
Standardized total and indirect effect of stress at T1 and infections during chemotherapy (T2), standard error (SE), 95% bias corrected confidence intervals (CI), ratio of indirect to total effect.
| Path |
Effect (β) |
SE |
95% BC CI |
Ratio of indirect to total effect |
|---|---|---|---|---|
| Total effect | 0.43∗ | 0.13 | [0.15 to 0.70] | |
| Indirect effect | ||||
| CD3+ number | 0.00 | 0.03 | [-0.03 to 0.10] | 1.7% |
| CD3+ ratio | 0.00 | 0.02 | [-0.06 to 0.05] | 0.1% |
| CD16+ number | 0.03 | 0.03 | [-0.03 to 0.15] | 7.1% |
| CD16+ ratio | 0.04 | 0.04 | [-0.02 to 0.15] | 10.4% |
| CD56+ number | −0.01 | 0.04 | [-0.15 to 0.04] | 1.8% |
| CD56+ ratio | −0.02 | 0.04 | [-0.16 to 0.02] | 5.6% |
| CD16+/56+ number | 0.02 | 0.04 | [-0.04 to 0.13] | 4.8% |
| CD16+/56+ ratio | 0.03 | 0.04 | [-0.04 to 0.11] | 6.4% |
| Neutrophils, absolute count | −0.01 | 0.03 | [-0.10 to 0.03] | 2.2% |
| Neutrophils, percentage | −0.01 | 0.03 | [-0.11 to 0.02] | 1.4% |
Note. The standardized beta (β) quantifies the variation of the dependent variable, in standard deviation, associated with each increase of one standard deviation on the independent variable (for total effect) or via a mediator (for indirect effect). N = 44 for all analyses except the percentage of neutrophils for which N = 39.
∗ Effects are significant at alpha = 5% when confidence intervals (CI) exclude zero.